| Holly Murphy Ritger, NP | |
|
10628 Park Rd, Charlotte, NC 28210-8407 | |
| (704) 667-7070 | |
| Not Available |
| Full Name | Holly Murphy Ritger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 10628 Park Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407488380 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
"U.S. envoys said there was progress in talks Wednesday on arrangements for the first U.S. government food aid shipment to impoverished North Korea in three years, part of an agreement aimed at ending Pyongyang's nuclear programs," the Associated Press reports.
Researchers from Roche Diagnostics have been testing a new assay known as the Elecsys assay.
DNA from the heart's own cells plays a role in heart failure by mistakenly activating the body's immune system, according to a study by British and Japanese researchers, co-funded by the British Heart Foundation.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
› Verified 6 days ago
| Entity Name | Caromont Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
"U.S. envoys said there was progress in talks Wednesday on arrangements for the first U.S. government food aid shipment to impoverished North Korea in three years, part of an agreement aimed at ending Pyongyang's nuclear programs," the Associated Press reports.
Researchers from Roche Diagnostics have been testing a new assay known as the Elecsys assay.
DNA from the heart's own cells plays a role in heart failure by mistakenly activating the body's immune system, according to a study by British and Japanese researchers, co-funded by the British Heart Foundation.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
› Verified 6 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
"U.S. envoys said there was progress in talks Wednesday on arrangements for the first U.S. government food aid shipment to impoverished North Korea in three years, part of an agreement aimed at ending Pyongyang's nuclear programs," the Associated Press reports.
Researchers from Roche Diagnostics have been testing a new assay known as the Elecsys assay.
DNA from the heart's own cells plays a role in heart failure by mistakenly activating the body's immune system, according to a study by British and Japanese researchers, co-funded by the British Heart Foundation.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Holly Murphy Ritger, NP Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Holly Murphy Ritger, NP 10628 Park Rd, Charlotte, NC 28210-8407 Ph: (704) 667-7070 |
News Archive
"U.S. envoys said there was progress in talks Wednesday on arrangements for the first U.S. government food aid shipment to impoverished North Korea in three years, part of an agreement aimed at ending Pyongyang's nuclear programs," the Associated Press reports.
Researchers from Roche Diagnostics have been testing a new assay known as the Elecsys assay.
DNA from the heart's own cells plays a role in heart failure by mistakenly activating the body's immune system, according to a study by British and Japanese researchers, co-funded by the British Heart Foundation.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
› Verified 6 days ago